On Friday, Shares of Cintas Corporation (NASDAQ:CTAS), subtract -1.16 % and closed at $110.46 in the last trading session. The last trading range of the stock ranges between $110.34 and $112.03. The company’s Market capitalization is $11.45 Billion with the total Outstanding Shares of 104.91Billion. During the 52-week trading session the minimum price at which share price traded, registered at $80.00 and reached to max level of $119.94. Cintas Corporation (CTAS) recently declared that its location in Columbus, IN received Voluntary Protection Program (VPP) Star certification from the Indiana Occupational Safety and Health Administration (IOSHA). VPP Star is their highest recognition for the practice of and commitment to exemplary occupational safety and health.
“One of the many benefits of achieving VPP is our employee-partners and their families know they are working for a company that puts their health and safety above all else,” stated Katy Cradick, General Manager. “They also know that safety is a team effort and they must continue to work together to create better safety habits at work and at home.”
The Columbus location employs almost 40 people in the state of Indiana.
Since 2011, a total of 44 Cintas facilities have been recognized under the VPP program; 11 of those sites are in Indiana. Cintas is presently ranked fourth in the entire nation for companies with VPP sites.
Shares of Zimmer Biomet Holdings Inc (NYSE:ZBH), added 0.17% and closed at $131.00 in the last trading session. The last trading range of the stock ranges between $130.04 and $131.25. The company’s Market capitalization is $26.24 Billion with the total Outstanding Shares of 200.01 Million. During the 52-week trading session the minimum price at which share price traded, registered at $88.27 and reached to max level of $133.19. Zimmer Biomet Holdings, Inc., together with its auxiliaries, provides musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates through four segments: Americas Spine, Bone Healing, Craniomaxillofacial and Thoracic (CMF), and Dental. It designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip reconstructive products; S.E.T. products, counting surgical, sports medicine, biologics, foot and ankle, extremities, and trauma products; dental products that include dental reconstructive implants, and dental prosthetic and regenerative products; and spine products comprising medical devices and surgical instruments. The company also offers face and skull reconstruction products, in addition to products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. In addition, it provides bone cement and bone healing products. The companys products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopaedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, in addition to agents, healthcare purchasing organizations, or buying groups.